This article is more than 5 years old. Information may no longer be current.

Nidek to offer Medmont E300 corneal topographer in US

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Nidek has partnered with Medmont International to offer the Medmont E300 corneal topographer in the United States, according to a Nidek press release.

The partnership will allow Nidek to add the topographer to its portfolio, as well as give Medmont a “well-respected partner in the ophthalmology space,” Robert Heavyside, president of Medmont, said in the release.

“It was an easy decision for Nidek Inc. to partner with Medmont and to go with the E300 topographer. We were impressed by the instrument’s ability to capture from limbus to limbus, plus having a noninvasive and accurate way of detecting dry eye was a big plus, too,” Motoki Ozawa, Nidek president and CEO, said in the release.